· ] Common Shares Axovant Sciences Ltd. UNDERWRITING AGREEMENTUnderwriting Agreement • June 1st, 2015 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York
Introductory. Axovant Sciences Ltd., a company incorporated and organized under the laws of Bermuda (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of [·] common shares, par value $0.00001 per common share (the “Shares”). The [·] Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional [·] Shares as provided in Section 2. The additional [·] Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” Jefferies LLC (“Jefferies”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional u
March 23, 2015 Marianne Romeo DinsmoreAxovant Sciences Ltd. • June 1st, 2015 • Pharmaceutical preparations
